Introduction: Pancreatic neuroendocrine tumors (PanNETs) are a heterogeneous group of neoplasms that varies from indolent to highly aggressive diseases. Previous studies have suggested alterations of ATRX/DAXX as biomarkers of dismal prognosis, yet inconclusive data (especially in the metastatic setting) prevent those biomarkers to be used as routine clinical tests.
Aim(s): We aimed at identifying mRNA-based prognostic classifier for PanNETs.
Materials and methods: We performed mRNA microarray expression analysis, high-coverage targeted DNA sequencing, and copy-number variation (CNV) analysis on 75 PanNETs. Principal component analysis (PCA) and gene set variation analysis (GSVA) were performed on mRNA data.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Basic Science - Genetics, epigenetics, miRNAs, Omics
Presenting Author: Dr Caterina Vicentini
, Barbi S
, Bersani S
, Rusev B
, Lawlor R T
, Cingarlini S
, Landoni L
, Pea A
, Sadanandam A
, Scarpa A
, Corbo V
To read results and conclusion, please login ...
Further abstracts you may be interested in